|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 31/225 | (2006.01) |
| A61P 25/00 | (2006.01) |
| (11) | Number of the document | 2139467 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08737369.2 |
| Date of filing the European patent application | 2008-02-07 | |
| (97) | Date of publication of the European application | 2010-01-06 |
| (45) | Date of publication and mention of the grant of the patent | 2016-09-21 |
| (46) | Date of publication of the claims translation | 2016-10-10 |
| (86) | Number | PCT/IB2008/000779 |
| Date | 2008-02-07 |
| (87) | Number | WO 2008/096271 |
| Date | 2008-08-14 |
| (30) | Number | Date | Country code |
| 888925 P | 2007-02-08 | US |
| (72) |
GOLD, Ralf, DE
|
| (73) |
Biogen MA Inc.,
225 Binney Street, Cambridge, MA 02142,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Neuroapsauga, sergant demielinizuojančia liga |
| NEUROPROTECTION IN DEMYELINATING DISEASES |
| Payment date | Validity (years) | Amount | |
| 2019-01-30 | 12 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2018-12-15 |